These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 17332916)
1. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells. Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916 [TBL] [Abstract][Full Text] [Related]
2. COX-2 overexpression increases motility and invasion of breast cancer cells. Singh B; Berry JA; Shoher A; Ramakrishnan V; Lucci A Int J Oncol; 2005 May; 26(5):1393-9. PubMed ID: 15809733 [TBL] [Abstract][Full Text] [Related]
3. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628 [TBL] [Abstract][Full Text] [Related]
4. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Johnson MD; Torri JA; Lippman ME; Dickson RB Exp Cell Res; 1999 Feb; 247(1):105-13. PubMed ID: 10047452 [TBL] [Abstract][Full Text] [Related]
5. IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells. Cheng CY; Hsieh HL; Sun CC; Lin CC; Luo SF; Yang CM J Cell Physiol; 2009 Apr; 219(1):183-93. PubMed ID: 19097143 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of human breast carcinoma cell invasiveness and urokinase plasminogen activator activity by glucose deprivation. Belkacemi L; Lam E; Caldwell JD; Siemens DR; Graham CH Exp Cell Res; 2006 Jun; 312(10):1685-92. PubMed ID: 16564525 [TBL] [Abstract][Full Text] [Related]
7. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086 [TBL] [Abstract][Full Text] [Related]
8. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645 [TBL] [Abstract][Full Text] [Related]
9. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression. Luparello C; Sirchia R; Pupello D J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357 [TBL] [Abstract][Full Text] [Related]
11. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells. Iwamoto J; Mizokami Y; Takahashi K; Matsuoka T; Matsuzaki Y Helicobacter; 2008 Jun; 13(3):174-82. PubMed ID: 18466392 [TBL] [Abstract][Full Text] [Related]
12. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells. Mi Z; Guo H; Wai PY; Gao C; Kuo PC Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180 [TBL] [Abstract][Full Text] [Related]
13. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase. Chambers SK; Wang Y; Gertz RE; Kacinski BM Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368 [TBL] [Abstract][Full Text] [Related]
14. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016 [TBL] [Abstract][Full Text] [Related]
15. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053 [TBL] [Abstract][Full Text] [Related]
16. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors. Tan M; Li P; Sun M; Yin G; Yu D Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820 [TBL] [Abstract][Full Text] [Related]
17. COX-2 induces IL-11 production in human breast cancer cells. Singh B; Berry JA; Shoher A; Lucci A J Surg Res; 2006 Apr; 131(2):267-75. PubMed ID: 16457848 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts. Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194 [TBL] [Abstract][Full Text] [Related]
19. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. Lai KC; Huang AC; Hsu SC; Kuo CL; Yang JS; Wu SH; Chung JG J Agric Food Chem; 2010 Mar; 58(5):2935-42. PubMed ID: 20136087 [TBL] [Abstract][Full Text] [Related]
20. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells. Pakneshan P; Szyf M; Rabbani SA Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]